| 标题 |
Twice-Yearly Depemokimab Demonstrates an Acceptable Safety Profile in a 12-Month Interim Analysis of the AGILE Phase III Open-Label Extension Study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Allergy and Clinical Immunology 作者:Daniel Jackson; Ian Pavord; Michael Wechsler; David Jackson; David Muccino; et al 出版日期:2025-02-10 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)